CCM
LVAC

Context Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Context Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-225,000
Closed -$2.31M – 424
2022
Q4 		$2.31M Buy
+225,000
New +$2.28M 0.17% 150
2022
Q2 		– Sell
-225,000
Closed -$2.25M – 692
2022
Q1 		$2.25M Buy
+225,000
New +$2.23M 0.15% 200

Other funds holding LVAC

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Context Capital Management's LVAC Position: Q1 2023 in Review

Context Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2023, closing a stake of 225,000 shares — an estimated $2.31M sold.

Context Capital Management first reported a position in LVAC in Q1 2022 and held it in 2 quarters. The position peaked at $2.31M in Q4 2022. 54 funds tracked by Wall St. Rank hold LVAC as of Q1 2023.

  • Context Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Context Capital Management sold 225,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.31M.
  • Context Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Context Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.31M in Q4 2022.
  • 54 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.